nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—HTR2B—Sorafenib—thyroid cancer	0.293	0.422	CbGbCtD
Lisuride—HTR2C—Sorafenib—thyroid cancer	0.191	0.275	CbGbCtD
Lisuride—CYP3A4—Vandetanib—thyroid cancer	0.0603	0.0869	CbGbCtD
Lisuride—CYP2D6—Sorafenib—thyroid cancer	0.0572	0.0823	CbGbCtD
Lisuride—CYP3A4—Sorafenib—thyroid cancer	0.0364	0.0524	CbGbCtD
Lisuride—CYP2D6—Doxorubicin—thyroid cancer	0.0347	0.05	CbGbCtD
Lisuride—CYP3A4—Doxorubicin—thyroid cancer	0.0221	0.0318	CbGbCtD
Lisuride—Pericarditis—Vandetanib—thyroid cancer	0.0152	0.083	CcSEcCtD
Lisuride—Pleural effusion—Sorafenib—thyroid cancer	0.00581	0.0316	CcSEcCtD
Lisuride—Dehydration—Vandetanib—thyroid cancer	0.00445	0.0242	CcSEcCtD
Lisuride—Blood pressure increased—Sorafenib—thyroid cancer	0.00445	0.0242	CcSEcCtD
Lisuride—Pericardial effusion—Epirubicin—thyroid cancer	0.00401	0.0218	CcSEcCtD
Lisuride—Pericarditis—Epirubicin—thyroid cancer	0.0038	0.0207	CcSEcCtD
Lisuride—Weight decreased—Vandetanib—thyroid cancer	0.00374	0.0204	CcSEcCtD
Lisuride—Pericardial effusion—Doxorubicin—thyroid cancer	0.00371	0.0202	CcSEcCtD
Lisuride—Pericarditis—Doxorubicin—thyroid cancer	0.00352	0.0191	CcSEcCtD
Lisuride—Cardiac disorder—Vandetanib—thyroid cancer	0.00307	0.0167	CcSEcCtD
Lisuride—Angiopathy—Vandetanib—thyroid cancer	0.003	0.0164	CcSEcCtD
Lisuride—Dehydration—Sorafenib—thyroid cancer	0.003	0.0163	CcSEcCtD
Lisuride—Mediastinal disorder—Vandetanib—thyroid cancer	0.00298	0.0162	CcSEcCtD
Lisuride—Mental disorder—Vandetanib—thyroid cancer	0.0029	0.0158	CcSEcCtD
Lisuride—Malnutrition—Vandetanib—thyroid cancer	0.00288	0.0157	CcSEcCtD
Lisuride—Abdominal discomfort—Sorafenib—thyroid cancer	0.00267	0.0146	CcSEcCtD
Lisuride—Weight decreased—Sorafenib—thyroid cancer	0.00252	0.0137	CcSEcCtD
Lisuride—Cough—Vandetanib—thyroid cancer	0.00251	0.0137	CcSEcCtD
Lisuride—Anxiety—Vandetanib—thyroid cancer	0.00244	0.0133	CcSEcCtD
Lisuride—Dry mouth—Vandetanib—thyroid cancer	0.0024	0.0131	CcSEcCtD
Lisuride—Infection—Vandetanib—thyroid cancer	0.00234	0.0127	CcSEcCtD
Lisuride—Nervous system disorder—Vandetanib—thyroid cancer	0.00231	0.0126	CcSEcCtD
Lisuride—Pleural effusion—Epirubicin—thyroid cancer	0.00215	0.0117	CcSEcCtD
Lisuride—Insomnia—Vandetanib—thyroid cancer	0.00213	0.0116	CcSEcCtD
Lisuride—Dyspnoea—Vandetanib—thyroid cancer	0.0021	0.0114	CcSEcCtD
Lisuride—Cardiac disorder—Sorafenib—thyroid cancer	0.00207	0.0113	CcSEcCtD
Lisuride—Decreased appetite—Vandetanib—thyroid cancer	0.00204	0.0111	CcSEcCtD
Lisuride—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00203	0.0111	CcSEcCtD
Lisuride—Fatigue—Vandetanib—thyroid cancer	0.00203	0.011	CcSEcCtD
Lisuride—Angiopathy—Sorafenib—thyroid cancer	0.00203	0.011	CcSEcCtD
Lisuride—Immune system disorder—Sorafenib—thyroid cancer	0.00202	0.011	CcSEcCtD
Lisuride—Mediastinal disorder—Sorafenib—thyroid cancer	0.00201	0.011	CcSEcCtD
Lisuride—Constipation—Vandetanib—thyroid cancer	0.00201	0.011	CcSEcCtD
Lisuride—Pleural effusion—Doxorubicin—thyroid cancer	0.00199	0.0108	CcSEcCtD
Lisuride—Mental disorder—Sorafenib—thyroid cancer	0.00196	0.0107	CcSEcCtD
Lisuride—Malnutrition—Sorafenib—thyroid cancer	0.00194	0.0106	CcSEcCtD
Lisuride—Syncope—Sorafenib—thyroid cancer	0.00174	0.00949	CcSEcCtD
Lisuride—Cough—Sorafenib—thyroid cancer	0.0017	0.00924	CcSEcCtD
Lisuride—Asthenia—Vandetanib—thyroid cancer	0.00169	0.00919	CcSEcCtD
Lisuride—Dry mouth—Sorafenib—thyroid cancer	0.00162	0.00881	CcSEcCtD
Lisuride—Infection—Sorafenib—thyroid cancer	0.00158	0.00858	CcSEcCtD
Lisuride—Nervous system disorder—Sorafenib—thyroid cancer	0.00156	0.00847	CcSEcCtD
Lisuride—Dizziness—Vandetanib—thyroid cancer	0.00155	0.00847	CcSEcCtD
Lisuride—Anorexia—Sorafenib—thyroid cancer	0.00151	0.00824	CcSEcCtD
Lisuride—Vomiting—Vandetanib—thyroid cancer	0.0015	0.00814	CcSEcCtD
Lisuride—Headache—Vandetanib—thyroid cancer	0.00147	0.00802	CcSEcCtD
Lisuride—Dyspnoea—Sorafenib—thyroid cancer	0.00141	0.0077	CcSEcCtD
Lisuride—Decreased appetite—Sorafenib—thyroid cancer	0.00138	0.00751	CcSEcCtD
Lisuride—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00137	0.00746	CcSEcCtD
Lisuride—Fatigue—Sorafenib—thyroid cancer	0.00137	0.00745	CcSEcCtD
Lisuride—Constipation—Sorafenib—thyroid cancer	0.00136	0.00739	CcSEcCtD
Lisuride—Asthenia—Sorafenib—thyroid cancer	0.00114	0.0062	CcSEcCtD
Lisuride—Dehydration—Epirubicin—thyroid cancer	0.00111	0.00604	CcSEcCtD
Lisuride—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00109	0.00593	CcSEcCtD
Lisuride—Dizziness—Sorafenib—thyroid cancer	0.00105	0.00571	CcSEcCtD
Lisuride—Dehydration—Doxorubicin—thyroid cancer	0.00103	0.00559	CcSEcCtD
Lisuride—Vomiting—Sorafenib—thyroid cancer	0.00101	0.00549	CcSEcCtD
Lisuride—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00101	0.00549	CcSEcCtD
Lisuride—Headache—Sorafenib—thyroid cancer	0.000994	0.00541	CcSEcCtD
Lisuride—Weight increased—Epirubicin—thyroid cancer	0.000938	0.00511	CcSEcCtD
Lisuride—Weight decreased—Epirubicin—thyroid cancer	0.000933	0.00508	CcSEcCtD
Lisuride—Sweating—Epirubicin—thyroid cancer	0.000881	0.0048	CcSEcCtD
Lisuride—Weight increased—Doxorubicin—thyroid cancer	0.000868	0.00473	CcSEcCtD
Lisuride—Weight decreased—Doxorubicin—thyroid cancer	0.000863	0.0047	CcSEcCtD
Lisuride—Sweating—Doxorubicin—thyroid cancer	0.000815	0.00444	CcSEcCtD
Lisuride—Oedema peripheral—Epirubicin—thyroid cancer	0.000813	0.00443	CcSEcCtD
Lisuride—Cardiac disorder—Epirubicin—thyroid cancer	0.000766	0.00417	CcSEcCtD
Lisuride—Oedema peripheral—Doxorubicin—thyroid cancer	0.000752	0.0041	CcSEcCtD
Lisuride—Angiopathy—Epirubicin—thyroid cancer	0.000749	0.00408	CcSEcCtD
Lisuride—Immune system disorder—Epirubicin—thyroid cancer	0.000745	0.00406	CcSEcCtD
Lisuride—Mediastinal disorder—Epirubicin—thyroid cancer	0.000744	0.00405	CcSEcCtD
Lisuride—Mental disorder—Epirubicin—thyroid cancer	0.000723	0.00394	CcSEcCtD
Lisuride—Malnutrition—Epirubicin—thyroid cancer	0.000718	0.00391	CcSEcCtD
Lisuride—Cardiac disorder—Doxorubicin—thyroid cancer	0.000709	0.00386	CcSEcCtD
Lisuride—Angiopathy—Doxorubicin—thyroid cancer	0.000693	0.00377	CcSEcCtD
Lisuride—Immune system disorder—Doxorubicin—thyroid cancer	0.00069	0.00376	CcSEcCtD
Lisuride—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000688	0.00375	CcSEcCtD
Lisuride—Mental disorder—Doxorubicin—thyroid cancer	0.000669	0.00364	CcSEcCtD
Lisuride—Malnutrition—Doxorubicin—thyroid cancer	0.000665	0.00362	CcSEcCtD
Lisuride—Vertigo—Epirubicin—thyroid cancer	0.000645	0.00352	CcSEcCtD
Lisuride—Syncope—Epirubicin—thyroid cancer	0.000644	0.00351	CcSEcCtD
Lisuride—Palpitations—Epirubicin—thyroid cancer	0.000635	0.00346	CcSEcCtD
Lisuride—Cough—Epirubicin—thyroid cancer	0.000627	0.00341	CcSEcCtD
Lisuride—Anxiety—Epirubicin—thyroid cancer	0.000609	0.00332	CcSEcCtD
Lisuride—Dry mouth—Epirubicin—thyroid cancer	0.000598	0.00326	CcSEcCtD
Lisuride—Vertigo—Doxorubicin—thyroid cancer	0.000597	0.00325	CcSEcCtD
Lisuride—Syncope—Doxorubicin—thyroid cancer	0.000596	0.00325	CcSEcCtD
Lisuride—Confusional state—Epirubicin—thyroid cancer	0.000591	0.00322	CcSEcCtD
Lisuride—Palpitations—Doxorubicin—thyroid cancer	0.000587	0.0032	CcSEcCtD
Lisuride—Infection—Epirubicin—thyroid cancer	0.000582	0.00317	CcSEcCtD
Lisuride—Cough—Doxorubicin—thyroid cancer	0.00058	0.00316	CcSEcCtD
Lisuride—Nervous system disorder—Epirubicin—thyroid cancer	0.000575	0.00313	CcSEcCtD
Lisuride—Tachycardia—Epirubicin—thyroid cancer	0.000572	0.00312	CcSEcCtD
Lisuride—Hyperhidrosis—Epirubicin—thyroid cancer	0.000567	0.00309	CcSEcCtD
Lisuride—Anxiety—Doxorubicin—thyroid cancer	0.000564	0.00307	CcSEcCtD
Lisuride—Anorexia—Epirubicin—thyroid cancer	0.000559	0.00304	CcSEcCtD
Lisuride—Dry mouth—Doxorubicin—thyroid cancer	0.000553	0.00301	CcSEcCtD
Lisuride—Confusional state—Doxorubicin—thyroid cancer	0.000547	0.00298	CcSEcCtD
Lisuride—Infection—Doxorubicin—thyroid cancer	0.000539	0.00294	CcSEcCtD
Lisuride—Nervous system disorder—Doxorubicin—thyroid cancer	0.000532	0.0029	CcSEcCtD
Lisuride—Insomnia—Epirubicin—thyroid cancer	0.00053	0.00289	CcSEcCtD
Lisuride—Tachycardia—Doxorubicin—thyroid cancer	0.000529	0.00288	CcSEcCtD
Lisuride—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000524	0.00286	CcSEcCtD
Lisuride—Dyspnoea—Epirubicin—thyroid cancer	0.000523	0.00285	CcSEcCtD
Lisuride—Somnolence—Epirubicin—thyroid cancer	0.000521	0.00284	CcSEcCtD
Lisuride—Anorexia—Doxorubicin—thyroid cancer	0.000517	0.00282	CcSEcCtD
Lisuride—Decreased appetite—Epirubicin—thyroid cancer	0.00051	0.00278	CcSEcCtD
Lisuride—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000506	0.00276	CcSEcCtD
Lisuride—Fatigue—Epirubicin—thyroid cancer	0.000505	0.00275	CcSEcCtD
Lisuride—Constipation—Epirubicin—thyroid cancer	0.000501	0.00273	CcSEcCtD
Lisuride—Insomnia—Doxorubicin—thyroid cancer	0.000491	0.00267	CcSEcCtD
Lisuride—Dyspnoea—Doxorubicin—thyroid cancer	0.000484	0.00263	CcSEcCtD
Lisuride—Feeling abnormal—Epirubicin—thyroid cancer	0.000483	0.00263	CcSEcCtD
Lisuride—Somnolence—Doxorubicin—thyroid cancer	0.000482	0.00263	CcSEcCtD
Lisuride—Decreased appetite—Doxorubicin—thyroid cancer	0.000472	0.00257	CcSEcCtD
Lisuride—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000468	0.00255	CcSEcCtD
Lisuride—Fatigue—Doxorubicin—thyroid cancer	0.000468	0.00255	CcSEcCtD
Lisuride—Constipation—Doxorubicin—thyroid cancer	0.000464	0.00253	CcSEcCtD
Lisuride—Feeling abnormal—Doxorubicin—thyroid cancer	0.000447	0.00243	CcSEcCtD
Lisuride—Asthenia—Epirubicin—thyroid cancer	0.000421	0.00229	CcSEcCtD
Lisuride—Asthenia—Doxorubicin—thyroid cancer	0.000389	0.00212	CcSEcCtD
Lisuride—Dizziness—Epirubicin—thyroid cancer	0.000388	0.00211	CcSEcCtD
Lisuride—Vomiting—Epirubicin—thyroid cancer	0.000373	0.00203	CcSEcCtD
Lisuride—Headache—Epirubicin—thyroid cancer	0.000367	0.002	CcSEcCtD
Lisuride—Dizziness—Doxorubicin—thyroid cancer	0.000359	0.00195	CcSEcCtD
Lisuride—Vomiting—Doxorubicin—thyroid cancer	0.000345	0.00188	CcSEcCtD
Lisuride—Headache—Doxorubicin—thyroid cancer	0.00034	0.00185	CcSEcCtD
Lisuride—ADRA2B—Hemostasis—AKT1—thyroid cancer	3.12e-05	0.000256	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—NRAS—thyroid cancer	3.12e-05	0.000255	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NRG1—thyroid cancer	3.11e-05	0.000255	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—BRAF—thyroid cancer	3.11e-05	0.000254	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—PTEN—thyroid cancer	3.1e-05	0.000254	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—KRAS—thyroid cancer	3.09e-05	0.000253	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TERT—thyroid cancer	3.08e-05	0.000252	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—NRAS—thyroid cancer	3.07e-05	0.000252	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—NRAS—thyroid cancer	3.07e-05	0.000252	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NRG1—thyroid cancer	3.06e-05	0.000251	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	3.04e-05	0.000249	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—AKT1—thyroid cancer	3.03e-05	0.000248	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TERT—thyroid cancer	3.03e-05	0.000248	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—KRAS—thyroid cancer	3.03e-05	0.000248	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	3.03e-05	0.000248	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PPARG—thyroid cancer	2.99e-05	0.000245	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.99e-05	0.000245	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—KRAS—thyroid cancer	2.98e-05	0.000244	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—HIF1A—thyroid cancer	2.94e-05	0.000241	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—BRAF—thyroid cancer	2.93e-05	0.00024	CbGpPWpGaD
Lisuride—ADRA2C—Hemostasis—AKT1—thyroid cancer	2.92e-05	0.000239	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—HIF1A—thyroid cancer	2.9e-05	0.000237	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—BRAF—thyroid cancer	2.89e-05	0.000237	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—BRAF—thyroid cancer	2.89e-05	0.000237	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—KRAS—thyroid cancer	2.84e-05	0.000233	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—TP53—thyroid cancer	2.81e-05	0.00023	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—NRAS—thyroid cancer	2.8e-05	0.000229	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TERT—thyroid cancer	2.79e-05	0.000229	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	2.78e-05	0.000228	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	2.78e-05	0.000227	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—NRAS—thyroid cancer	2.77e-05	0.000227	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TERT—thyroid cancer	2.75e-05	0.000225	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—HRAS—thyroid cancer	2.68e-05	0.00022	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—KRAS—thyroid cancer	2.68e-05	0.00022	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	2.68e-05	0.000219	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—HIF1A—thyroid cancer	2.67e-05	0.000219	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	2.67e-05	0.000218	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—KRAS—thyroid cancer	2.65e-05	0.000217	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—KRAS—thyroid cancer	2.65e-05	0.000217	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—BRAF—thyroid cancer	2.63e-05	0.000216	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—HRAS—thyroid cancer	2.63e-05	0.000215	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	2.63e-05	0.000215	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	2.61e-05	0.000214	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—TPR—thyroid cancer	2.61e-05	0.000214	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	2.59e-05	0.000212	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—HRAS—thyroid cancer	2.57e-05	0.000211	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.57e-05	0.00021	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—AKT1—thyroid cancer	2.55e-05	0.000209	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	2.55e-05	0.000209	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—HRAS—thyroid cancer	2.53e-05	0.000207	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—BRAF—thyroid cancer	2.52e-05	0.000206	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—RXRA—thyroid cancer	2.51e-05	0.000205	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—BRAF—thyroid cancer	2.51e-05	0.000205	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—AKT1—thyroid cancer	2.5e-05	0.000205	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TERT—thyroid cancer	2.5e-05	0.000205	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CCND1—thyroid cancer	2.46e-05	0.000202	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—AKT1—thyroid cancer	2.46e-05	0.000202	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	2.44e-05	0.0002	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PPARG—thyroid cancer	2.43e-05	0.000199	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—HRAS—thyroid cancer	2.42e-05	0.000198	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CCND1—thyroid cancer	2.41e-05	0.000198	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—KRAS—thyroid cancer	2.41e-05	0.000197	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	2.4e-05	0.000196	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	2.39e-05	0.000196	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	2.39e-05	0.000196	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—KRAS—thyroid cancer	2.38e-05	0.000195	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—PTEN—thyroid cancer	2.38e-05	0.000195	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CCND1—thyroid cancer	2.37e-05	0.000194	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—AKT1—thyroid cancer	2.37e-05	0.000194	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PTGS2—thyroid cancer	2.35e-05	0.000193	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—NRAS—thyroid cancer	2.35e-05	0.000193	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—AKT1—thyroid cancer	2.35e-05	0.000192	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—PTEN—thyroid cancer	2.33e-05	0.000191	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—AKT1—thyroid cancer	2.32e-05	0.00019	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	2.31e-05	0.00019	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	2.31e-05	0.000189	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	2.29e-05	0.000188	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—PTEN—thyroid cancer	2.29e-05	0.000188	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—HRAS—thyroid cancer	2.28e-05	0.000187	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—AKT1—thyroid cancer	2.27e-05	0.000186	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CCND1—thyroid cancer	2.27e-05	0.000186	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—HRAS—thyroid cancer	2.25e-05	0.000184	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—HRAS—thyroid cancer	2.25e-05	0.000184	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—AKT1—thyroid cancer	2.24e-05	0.000183	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	2.23e-05	0.000183	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	2.22e-05	0.000182	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—BRAF—thyroid cancer	2.21e-05	0.000181	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	2.2e-05	0.00018	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—PTEN—thyroid cancer	2.19e-05	0.000179	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	2.19e-05	0.000179	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	2.19e-05	0.000179	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—BRAF—thyroid cancer	2.18e-05	0.000178	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CCND1—thyroid cancer	2.14e-05	0.000175	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—AKT1—thyroid cancer	2.13e-05	0.000175	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—NRAS—thyroid cancer	2.12e-05	0.000174	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TP53—thyroid cancer	2.12e-05	0.000174	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	2.11e-05	0.000173	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CCND1—thyroid cancer	2.11e-05	0.000173	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	2.11e-05	0.000172	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—NRAS—thyroid cancer	2.08e-05	0.00017	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—PTEN—thyroid cancer	2.06e-05	0.000169	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PTEN—thyroid cancer	2.05e-05	0.000168	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—HRAS—thyroid cancer	2.05e-05	0.000168	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—NRAS—thyroid cancer	2.04e-05	0.000167	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	2.04e-05	0.000167	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—PTEN—thyroid cancer	2.04e-05	0.000167	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	2.03e-05	0.000166	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—HRAS—thyroid cancer	2.03e-05	0.000166	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—KRAS—thyroid cancer	2.02e-05	0.000166	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—AKT1—thyroid cancer	2.01e-05	0.000165	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—AKT1—thyroid cancer	1.99e-05	0.000163	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.99e-05	0.000163	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	1.99e-05	0.000163	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—AKT1—thyroid cancer	1.99e-05	0.000163	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	1.98e-05	0.000162	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	1.97e-05	0.000162	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.96e-05	0.000161	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.95e-05	0.00016	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—NRAS—thyroid cancer	1.95e-05	0.00016	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.95e-05	0.00016	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CCND1—thyroid cancer	1.92e-05	0.000157	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PTGS2—thyroid cancer	1.91e-05	0.000157	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.91e-05	0.000156	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	1.9e-05	0.000156	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	1.9e-05	0.000155	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.9e-05	0.000155	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	1.87e-05	0.000153	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—PTEN—thyroid cancer	1.85e-05	0.000152	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	1.84e-05	0.000151	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—NRAS—thyroid cancer	1.84e-05	0.000151	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.84e-05	0.000151	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	1.84e-05	0.000151	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.83e-05	0.00015	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—KRAS—thyroid cancer	1.83e-05	0.00015	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	1.82e-05	0.000149	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—NRAS—thyroid cancer	1.82e-05	0.000149	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	1.81e-05	0.000149	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	1.81e-05	0.000148	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—AKT1—thyroid cancer	1.81e-05	0.000148	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	1.79e-05	0.000147	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—AKT1—thyroid cancer	1.79e-05	0.000147	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—KRAS—thyroid cancer	1.79e-05	0.000146	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	1.78e-05	0.000146	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.77e-05	0.000145	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1.76e-05	0.000145	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—KRAS—thyroid cancer	1.76e-05	0.000144	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	1.75e-05	0.000143	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	1.73e-05	0.000142	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	1.72e-05	0.000141	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—HRAS—thyroid cancer	1.72e-05	0.000141	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	1.72e-05	0.000141	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	1.69e-05	0.000139	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	1.69e-05	0.000138	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—KRAS—thyroid cancer	1.68e-05	0.000138	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	1.67e-05	0.000137	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	1.67e-05	0.000137	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PTEN—thyroid cancer	1.67e-05	0.000137	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—NRAS—thyroid cancer	1.65e-05	0.000136	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	1.65e-05	0.000135	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	1.65e-05	0.000135	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—RXRA—thyroid cancer	1.64e-05	0.000134	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	1.64e-05	0.000134	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TP53—thyroid cancer	1.62e-05	0.000133	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCND1—thyroid cancer	1.61e-05	0.000132	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TP53—thyroid cancer	1.59e-05	0.00013	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCND1—thyroid cancer	1.59e-05	0.00013	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—KRAS—thyroid cancer	1.58e-05	0.00013	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PPARG—thyroid cancer	1.58e-05	0.00013	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—NRAS—thyroid cancer	1.58e-05	0.00013	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—NRAS—thyroid cancer	1.57e-05	0.000129	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TP53—thyroid cancer	1.56e-05	0.000128	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—KRAS—thyroid cancer	1.56e-05	0.000128	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	1.56e-05	0.000128	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—PTEN—thyroid cancer	1.56e-05	0.000128	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—HRAS—thyroid cancer	1.55e-05	0.000127	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	1.54e-05	0.000126	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—PTEN—thyroid cancer	1.53e-05	0.000126	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	1.53e-05	0.000125	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—HRAS—thyroid cancer	1.52e-05	0.000124	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—AKT1—thyroid cancer	1.52e-05	0.000124	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	1.51e-05	0.000123	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	1.5e-05	0.000123	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—HRAS—thyroid cancer	1.5e-05	0.000123	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	1.5e-05	0.000122	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TP53—thyroid cancer	1.49e-05	0.000122	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	1.44e-05	0.000118	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—HRAS—thyroid cancer	1.43e-05	0.000117	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—KRAS—thyroid cancer	1.42e-05	0.000117	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	1.41e-05	0.000116	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TP53—thyroid cancer	1.41e-05	0.000115	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	1.39e-05	0.000114	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NRAS—thyroid cancer	1.39e-05	0.000114	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TP53—thyroid cancer	1.39e-05	0.000114	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TP53—thyroid cancer	1.39e-05	0.000114	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—AKT1—thyroid cancer	1.37e-05	0.000112	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NRAS—thyroid cancer	1.37e-05	0.000112	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—KRAS—thyroid cancer	1.36e-05	0.000112	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	1.36e-05	0.000111	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—KRAS—thyroid cancer	1.36e-05	0.000111	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—HRAS—thyroid cancer	1.35e-05	0.00011	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—AKT1—thyroid cancer	1.34e-05	0.00011	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	1.33e-05	0.000109	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—HRAS—thyroid cancer	1.33e-05	0.000109	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—AKT1—thyroid cancer	1.32e-05	0.000108	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	1.32e-05	0.000108	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	1.3e-05	0.000106	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TP53—thyroid cancer	1.27e-05	0.000104	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—AKT1—thyroid cancer	1.26e-05	0.000103	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TP53—thyroid cancer	1.25e-05	0.000103	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PTGS2—thyroid cancer	1.25e-05	0.000102	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	1.24e-05	0.000102	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TP53—thyroid cancer	1.21e-05	9.92e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—HRAS—thyroid cancer	1.21e-05	9.91e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TP53—thyroid cancer	1.2e-05	9.87e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	1.2e-05	9.82e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—KRAS—thyroid cancer	1.2e-05	9.8e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—AKT1—thyroid cancer	1.19e-05	9.74e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—AKT1—thyroid cancer	1.18e-05	9.69e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—KRAS—thyroid cancer	1.18e-05	9.64e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	1.17e-05	9.61e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—AKT1—thyroid cancer	1.17e-05	9.61e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TP53—thyroid cancer	1.17e-05	9.6e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—HRAS—thyroid cancer	1.16e-05	9.48e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TP53—thyroid cancer	1.15e-05	9.44e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—HRAS—thyroid cancer	1.15e-05	9.43e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	1.12e-05	9.18e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	1.1e-05	9.03e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PTEN—thyroid cancer	1.09e-05	8.9e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	1.07e-05	8.77e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—AKT1—thyroid cancer	1.07e-05	8.75e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TP53—thyroid cancer	1.06e-05	8.71e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	1.06e-05	8.67e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TP53—thyroid cancer	1.05e-05	8.57e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PPARG—thyroid cancer	1.04e-05	8.48e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—AKT1—thyroid cancer	1.02e-05	8.37e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—AKT1—thyroid cancer	1.02e-05	8.33e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—HRAS—thyroid cancer	1.02e-05	8.33e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—HRAS—thyroid cancer	1e-05	8.19e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	9.89e-06	8.1e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	9.74e-06	7.97e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—AKT1—thyroid cancer	9.61e-06	7.87e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TP53—thyroid cancer	9.51e-06	7.79e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	9.1e-06	7.45e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—AKT1—thyroid cancer	8.98e-06	7.35e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—AKT1—thyroid cancer	8.83e-06	7.23e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PTGS2—thyroid cancer	8.15e-06	6.67e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	8.03e-06	6.58e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PTEN—thyroid cancer	7.1e-06	5.82e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—AKT1—thyroid cancer	6.26e-06	5.13e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—AKT1—thyroid cancer	4.09e-06	3.35e-05	CbGpPWpGaD
